Invizyne

Nature provides us with countless chemicals that can improve our lives. Trees and plants often supply them, but in such small amounts that theyre hard to extract, leading to waste and environmental degradation. To harness natural chemicals more effectively, synthetic biology first attempted to rewire living cells to make them easier to extract. But cells are complicated and not easily rewired. Invizynes new approach, SimplePath streamlines synthetic biology by removing cells altogether, along with their complexities. Using our proprietary, sustainable enzyme systems we can build simple, efficient reactors for chemical production

Synthetic biology,synbio,cell free,biotechnology,biomanufacturing,natural chemicals,enzymatic pathways,chemicals,pharmaceuticals,and cannabinoids

Invizyne operates in the Biotechnology industry.

Invizyne's revenue is 11m - 100m

Invizyne has 11 - 50 employees.